|
2025
|
Invention
|
Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with msh3 ... |
|
|
G/S
|
Préparations pharmaceutiques. |
|
|
G/S
|
Pharmaceutical preparations. |
|
|
G/S
|
Computer software applications, downloadable. Medical services. |
|
2024
|
G/S
|
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders |
|
|
G/S
|
Healthcare provider and medical professional support program providing disease awareness and dise... |
|
2023
|
Invention
|
Use of maribavir in treatment regimens.
Characterization of drug-drug interaction properties and... |
|
|
Invention
|
Aminothiazole compounds as c-kit inhibitors.
The invention relates to c-Kit inhibitors useful in... |
|
|
Invention
|
Methods for the treatment of neurodegenerative disorders.
The present disclosure features useful... |
|
|
Invention
|
Methods for the treatment of nucleotide repeat expansion disorders associated with msh3 activity.... |
|
|
Invention
|
Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-... |
|
2022
|
G/S
|
Pharmaceuticals for use in the treatment of cancer and blood diseases and disorders Medical resea... |
|
|
G/S
|
Pharmaceuticals for use in the treatment of cancer and blood
diseases and disorders. Medical res... |
|
|
G/S
|
Pharmaceuticals; pharmaceuticals for use in the treatment of cancer and blood diseases and disord... |
|
2021
|
Invention
|
Substituted acetylenic pyrazolo[1,5-a]pyridine compounds as kinase inhibitors.
This invention re... |
|
|
Invention
|
Aminothiazole compounds as c-kit inhibitors. The invention relates to c-Kit inhibitors useful in ... |
|
|
G/S
|
Pharmaceutical patient assistance program providing financial assistance for impoverished people ... |
|
2020
|
G/S
|
Downloadable predictive analytic software being risk
assessment software tools for use in patien... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology. |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
|
G/S
|
Préparations pharmaceutiques à utiliser en oncologie, nommément préparations pharmaceutiques pour... |
|
|
G/S
|
Pharmaceutical preparations used in oncology. |
|
|
G/S
|
Pharmaceutical patient support programs providing inflammatory bowel patients, patient caregivers... |
|
2019
|
Invention
|
Methods for the treatment of trinucleotide repeat exapnsion disorders associated with ogg1 activi... |
|
|
Invention
|
Methods for the treatment of trinucleotide repeat expansion disorders associated with mlh3 activi... |
|
|
Invention
|
Methods for the treatment of trinucleotide repeat expansion disorders associated with msh3 activi... |
|
|
Invention
|
Methods for the treatment of trinucleotide repeat expansion disorders associated with mlh1 activi... |
|
|
G/S
|
Providing medical information to patients relating to the management of malignancies and cancer; ... |
|
2018
|
Invention
|
Crystalline forms of 3-(imidazo[1,2-b)pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology |
|
2017
|
Invention
|
Aminothiazole compounds as c-kit inhibitors. 3, and n are described herein.
|
|
|
Invention
|
Methods of treatment and compositions with xanthine oxidase inhibitors.
Methods and pharmaceutic... |
|
|
Invention
|
Anilinopyrimidines as haematopoietic progenitor kinase 1 (hpk1) inhibitors. 4, m, and n are descr... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of constipation |
|
|
Invention
|
Inducible binding proteins and methods of use.
Provided herein are conditionally activated polyp... |
|
|
G/S
|
Pharmaceutical preparations for human use, namely, for the
treatment of hematological malignanci... |
|
|
G/S
|
Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancie... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of disorders of the central nervous system. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of attention deficit hyperactivity disorder |
|
|
G/S
|
Therapeutic and pharmaceutical preparations for use in the treatment of cancer, autoimmune disord... |
|
|
G/S
|
Hosting an interactive website featuring technology allowing
users to construct a representation... |
|
|
G/S
|
Pharmaceutical preparations acting on the central nervous
system; pharmaceutical preparations fo... |
|
2016
|
Invention
|
Crystalline forms of 3-(imidazo[1,2-b] pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1... |
|
|
G/S
|
Maintaining a registry of patient data and medical information, in the field of anaplastic lympho... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of gastrointestinal disorders, diseases involving v... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology; pharmaceutical preparations and substances for t... |
|
|
G/S
|
Pharmaceutical preparations for use in oncology. |
|
|
Invention
|
Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors... |
|
|
Invention
|
Method for treating schizophrenia comprising administering lurasidone. Disclosed herein are metho... |
|
2015
|
G/S
|
Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders |
|
|
G/S
|
Drug delivery apparatus, namely, injection instruments without needles for the delivery of pharma... |
|
|
Invention
|
Methods for treating heartburn, gastric bleeding or hemorrhage in patients receiving clopidogrel ... |
|
|
Invention
|
Multiple ppi dosage form. Herein provided are dosage forms (variously referred to as “formulation... |
|
2014
|
Invention
|
Pharmaceutical compositions and methods for treating age-related macular degeneration with melato... |
|
|
Invention
|
Substituted acetylenic pyrazolo[1,5-a]pyrimidines as kinase inhibitors. This invention relates to... |
|
|
Invention
|
Methods of treatment and compositions with xanthine oxidase inhibitors. Methods and pharmaceutica... |
|
|
Invention
|
Methods for treating hypertension.
The present invention relates to methods of treating subjects... |
|
2013
|
Invention
|
Methods for administration of colchicine with grapefruit juice.
Methods for safe administration ... |
|
|
Invention
|
Colchicine formulations; methods of making; and methods of use thereof.
Disclosed are new photos... |
|
|
Invention
|
Colchicine formulations; methods of making; and methods of use thereof. Disclosed are new photost... |
|
|
Invention
|
Substituted acetylenic imidazo[1,2-a]pyridazines as kinase inhibitors. This invention relates to ... |
|
|
Invention
|
Substituted acetylenic imidazo[1,2-a]pyrazine compounds as kinase inhibitors. This invention rela... |
|
|
Invention
|
Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors.... |
|
2012
|
Invention
|
Methods for treating hypertension in black patients.
The present invention relates to methods of... |
|
|
Invention
|
Combinations of azilsartan and chlorthalidone for treating hypertension black patients. The prese... |
|
|
Invention
|
Methods for treating heartburn and/or preventing gastric bleeding or hemorrhage in patients recei... |
|
2011
|
Invention
|
Methods for stabilizing joint damage in subjects using xanthine oxidoreductase inhibitors.
The p... |
|
2010
|
Invention
|
Sorbitol/dexlansoprazole co-crystals and method for making same. A crystal of dexlansoprazole and... |
